Get started
Author

Nikolaos Kamperidis

Observed names: N Kamperidis, N. Kamperidis, Nik Kamperidis, Nikolaos Kamperidis Nikolaos Kamperidis
Observed institutions: Barts Health NHS Trust, London North West Healthcare NHS Trust, Central Middlesex Hospital, King's College Hospital, St Mark's Hospital, Imperial College London
ORCID: 0000-0003-2543-1723
Observed ORCID: 0000-0003-2543-1723
OpenAlex ID: A5002034306
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
2021 · Nicholas A Kennedy, Simeng Lin, et al. · Gut · 273
PDF
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 105
PDF
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study
2018 · Uri Kopylov, Bram Verstockt, et al. · Inflammatory Bowel Diseases · 75
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2022 · Zhigang Liu, Kaixing Le, et al. · The Lancet. Gastroenterology & hepatology · 36
Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment
2020 · Nikolaos Kamperidis, Vasileios Kamperidis, et al. · Angiology · 30
Prevalence of malnutrition in medical and surgical gastrointestinal outpatients
2019 · N. Kamperidis, L. Tesser, et al. · Clinical Nutrition ESPEN · 21
Impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: real world data from a retrospective single centre cohort study
2019 · Nikolaos Kamperidis, Paul Middleton, et al. · Frontline Gastroenterology · 19
PDF
Single incision laparoscopic assisted double balloon enteroscopy: a novel technique to manage small bowel pathology
2020 · Ioannis Stasinos, Nikolaos Kamperidis, et al. · Surgical Endoscopy · 17
Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Left Ventricular Thrombus After Myocardial Infarction: A Meta-Analysis
2024 · Christos Gogos, Vasileios Anastasiou, et al. · The American Journal of Cardiology · 12
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease
2024 · Konstantinos Papamichael, Andrea Centritto, et al. · Clinical Gastroenterology and Hepatology · 12
PDF
The role of IL-19, IL-24, IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: A narrative review
2024 · Alexandros Toskas, Stefanos Milias, et al. · Arab Journal of Gastroenterology · 12
Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship
2024 · Gyanaranjan Nayak, Kyriakos Dimitriadis, et al. · Life · 10
PDF
Diagnosing Heart Failure with Preserved Ejection Fraction in Obese Patients
2025 · Marino Basha, Evdoxia Stavropoulou, et al. · Journal of Clinical Medicine · 9
Neurological disorders and small bowel dysmotility
2022 · Nikolaos Kamperidis, Jeremy Nightingale · Current Opinion in Gastroenterology · 9
Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
2019 · Rishi K Fofaria, Susan Barber, et al. · BMJ Open Quality · 8
PDF
Endoscopic Full Thickness Resection Device (FTRD®) for the Management of Gastrointestinal Lesions: Current Evidence and Future Perspectives
2025 · Magdalini Manti, Apostolis Papaefthymiou, et al. · Diagnostics · 7
PDF
What is the patient's and multidisciplinary team's perspective on telephone clinics?
2021 · Sonia Bouri, Roosey Sheth, et al. · British Journal of Healthcare Management · 7
Narrow-Band Imaging for the Detection of Early Gastric Cancer Among High-Risk Patients: A Systematic Review and Meta-Analysis
2025 · Magdalini Manti, Paraskevas Gkolfakis, et al. · Medicina · 6
PDF
A User’s Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease
2020 · Naila Arebi, Lovesh Dyall, et al. · Clinical Gastroenterology and Hepatology · 5
The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study
2025 · Uria Shani, Monica State, et al. · Journal of Crohn s and Colitis · 4
PDF
P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
2024 · D Al-Zarrad, K Yeung, et al. · Journal of Crohn s and Colitis · 3
PDF
DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation study
2018 · U Kopylov, B Verstockt, et al. · Journal of Crohn s and Colitis · 3
OC-159 Content analysis of illness blogs posted online by patients with IBD
2012 · N Tshuma, S Aboulela, et al. · Gut · 3
PDF
P1012 Real-world comparative effectiveness of risankizumab versus other biologics in perianal Crohn’s disease: a multicentre retrospective cohort study
2026 · A Dakka, L Van Lierop, et al. · Journal of Crohn s and Colitis · 2
P0519 Upadacitinib in Acute Severe Ulcerative Colitis among previously anti-TNFa exposed patients
2025 · M Manti, N Kamperidis, et al. · Journal of Crohn s and Colitis · 2
Works count: 67
Citation count: 705
H-index: 11
I10-index: 12
Year
Topic
Type